Search research articles
Contact Us
Filters
Showing results (71-80 of 90) with videos related to
Page
of 9
Sort By:
ACS Omega
|
April 17, 2023
Efficient Synergistic Antibacterial Activity of α-MSH Using Chitosan-Based Versatile Nanoconjugates
Sourav Barman, Asmita Chakraborty, Sujata Saha, et al.
Journal of Materials Chemistry. B
|
January 21, 2025
Concurrent targeted delivery of doxorubicin and curcumin to the cancer cells using simple and versatile ligand-installed multifaceted chitosan-based nanoconjugates
Sourav Barman, Sayoni Maitra Roy, Purvi Kishore, et al.
Clinical Genitourinary Cancer
|
August 29, 2024
Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab
Moshe C Ornstein, Laeth George, Wei Wei, et al.
JCO Precision Oncology
|
December 18, 2024
Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell Carcinoma
Arnab Basu, Cherry Au, Ajitha Kommalapati, et al.
Future Oncology (London, England)
|
May 16, 2026
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma
Matthew D Galsky, Alexandra Drakaki, Arnab Basu, et al.
Journal of Virology
|
January 29, 2011
Identification of a small-molecule entry inhibitor for filoviruses
Arnab Basu, Bing Li, Debra M Mills, et al.
Journal of Virology
|
November 8, 2013
New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion
Arnab Basu, Aleksandar Antanasijevic, Minxiu Wang, et al.
The Oncologist
|
March 11, 2022
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer
Meredith N Freeman, Albert Jang, Jason Zhu, et al.
The Journal of Clinical Investigation
|
April 23, 2024
Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles
Pedro Barata, Shuchi Gulati, Andrew Elliott, et al.
Lancet (London, England)
|
September 16, 2024
Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study
Toni K Choueiri, Laurence Albiges, Philippe Barthélémy, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 90) with videos related to
Sort By:
Page
of 9
ACS Omega
|
April 17, 2023
Efficient Synergistic Antibacterial Activity of α-MSH Using Chitosan-Based Versatile Nanoconjugates
Sourav Barman, Asmita Chakraborty, Sujata Saha, et al.
Journal of Materials Chemistry. B
|
January 21, 2025
Concurrent targeted delivery of doxorubicin and curcumin to the cancer cells using simple and versatile ligand-installed multifaceted chitosan-based nanoconjugates
Sourav Barman, Sayoni Maitra Roy, Purvi Kishore, et al.
Clinical Genitourinary Cancer
|
August 29, 2024
Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab
Moshe C Ornstein, Laeth George, Wei Wei, et al.
JCO Precision Oncology
|
December 18, 2024
Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell Carcinoma
Arnab Basu, Cherry Au, Ajitha Kommalapati, et al.
Future Oncology (London, England)
|
May 16, 2026
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma
Matthew D Galsky, Alexandra Drakaki, Arnab Basu, et al.
Journal of Virology
|
January 29, 2011
Identification of a small-molecule entry inhibitor for filoviruses
Arnab Basu, Bing Li, Debra M Mills, et al.
Journal of Virology
|
November 8, 2013
New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion
Arnab Basu, Aleksandar Antanasijevic, Minxiu Wang, et al.
The Oncologist
|
March 11, 2022
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer
Meredith N Freeman, Albert Jang, Jason Zhu, et al.
The Journal of Clinical Investigation
|
April 23, 2024
Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles
Pedro Barata, Shuchi Gulati, Andrew Elliott, et al.
Lancet (London, England)
|
September 16, 2024
Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study
Toni K Choueiri, Laurence Albiges, Philippe Barthélémy, et al.
Page
of 9